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Problem Identification
• Human Papillomavirus (HPV) is the most prevalent sexually transmitted infection in the United States.1
• Although the HPV vaccine has been proven to be effective and safe, the vaccination rates are significantly less
compared to other vaccines.2
• In men, HPV infection may lead to the development of numerous forms of cancer including oropharyngeal,
anal and penile.3
Cancer diagnoses related to HPV each year in the United States
Oropharyngeal
Cervical
Anal
Vulvar
Penile
Vaginal
Total

Women

Men

2,200
10,900
4,200
2,800
0
600
20,700

11,300
0
2,000
0
800
0
14,100

• According to the 2019 CDC National Immunization Survey, adolescents 13-17 years old were up to date with:2
•
•
•
•
•

HPV Vaccination: Males (48.7%), Females (53.7%)
Tdap Vaccination: 88.9%
Varicella Vaccination: 90.8%
MMR Vaccination: 91.9%
Hep B Vaccination: 92.1%
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Problem Identification

•

In 2016, sixty-nine NCI-Designed Cancer Centers determined that the low rate of HPV vaccination in the United States is a
serious public health threat.4

•

According to a report approved by the National Vaccine Advisory Committee in 2015, two significant barriers for HPV
vaccination were weak and inconsistent provider recommendations and low parental demand.5

•

The graph below demonstrates the relative change in incidence of high-grade cervical lesions by birth cohort 1980-1994
compared to 1979 in the state of Connecticut most likely due to HPV vaccination.6

•

Similar studies have not been done with male HPV-related cancers in Connecticut.

•

Due to the success of the HPV vaccine in the prevention of cervical cancer, men in the recommended age group should be
advised to receive the vaccination to prevent oropharyngeal, anal and penile cancers.
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Public Health Costs
• In the United States, the cost per HPV vaccination is estimated to be $360-$600 per
person while the average cost of treatment for oropharyngeal cancer $40,463.80. 7, 8
• Connecticut’s vaccination budget expanded to include the HPV vaccination for
patients through the Connecticut Vaccine Program (CVP).
•

“Beginning January 1, 2018, providers can order HPV vaccine for all 11 and 12 year old patients in their
practice, including those with private insurance.” – Mick Boldue (Vaccine Coordinator – CVP)

• In 2003, in the United States, the cost of new cases of mouth and oropharyngeal
cancer related to HPV was estimated to be $38.1 million (range, $17.7-$54 million). 8
• The cost of the increase in HPV driven cancers in both males and females has been
greatly underestimated and ignored in the United States and other countries around
the world.9
•

One study in the United Kingdom demonstrated that the annual cost for HPV related
oropharyngeal cancer is 80 million dollars while the cost to vaccinate every male would cost between
25-28 million dollars.9
3

Community Perspective
In order to gain a community perspective, I interviewed four medical providers at the Newtown Family
Medicine Clinic in Newtown, CT about the barriers for HPV vaccination in males and discussed ideas for
improvement with six other providers in the practice.
•

•

What do you believe are the major barriers for male patients to receive the HPV vaccination?
•

“Many people do not know that HPV can affect males as well. It is important to educate families that the vaccine is best started before sexual
activity and to ensure that they understand that getting the vaccine doesn’t imply that the child will start having sex soon” – Dr. Chang MD

•

“The misinformation on social media is a big barrier as well as the lack of knowledge of HPV risks and how it is spread. I think there is
information that is misrepresented and manipulated against vaccination. The whole thing needs to be broken down and explained properly,
including the science behind the new evidence, risks, rewards, links to cancer, etc.” – Hannah Fischetto - Medical Assistant

•

“One big challenge for males to get vaccinated is that many times their families believe that only females need it since males do not have a cervix
therefore are not at risk for cervical cancer. It is important that males are educated on HPV related cancers in men and future prevention for
their partners.” – Ms. Khuen – APRN

•

“Many parents do not understand how their son can get HPV and the role in transmission they may have” – Kathleen D’Orso APRN

Ideas on how to improve the understanding of the importance of HPV vaccination after speaking with
multiple medical providers at Newtown Family Medicine.
•

Many providers mentioned that a pamphlet to educate a parent before the HPV vaccination is advised would be very helpful and informative.

•

We discussed that making various resources available for patients including educational literature, YouTube advertisements and commercials
would help more parents understand the importance of vaccination.
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Intervention
•

A survey was created and given to medical providers at Newtown Family Medicine to aid in understanding the perceived
barriers to HPV vaccination in Newtown, CT, in order to create an appropriate brochure for the clinic.
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Intervention
•

With insight provided by the survey, a trifold brochure was designed using data provided by the CDC regarding HPV vaccination.

•

The brochures were given to providers and patients as well as placed in rooms around the Newtown Family Medicine Clinic.

Boys can develop HPV cancers as adults
HPV does not only affect females.
Approximately 4 out of 10 cases of cancer
caused by HPV occur among men.

For more information:
Visit
www.cdc.gov/hpv/parents/vaccine.html

and ask your doctor

80% of people will get an HPV infection
in their lifetime
•

About 14 million Americans become
infected with HPV each year

HPV vaccination prevents cancer
•

Two doses of the HPV vaccine are
recommended for all boys and
girls at ages 11-12
Dose #1
11- 12 years

HPV vaccination has proven to be safe
and effective at providing long-lasting
protection

Dose #2
6-12 months after
the first dose

Recommended for everyone
through age 26 years, if not
vaccinated already
• If vaccines are started after age
15, three shots are given over
six months

HPV is estimated to cause nearly
35,000 cases of cancer in men and
women each year in the US

•

Newtown Primary Care
170 Mount Pleasant Rd
Newtown, CT 06470
Phone: (203) 426-1818
Fax: (203) 426-8253

Over 100 million doses have been
distributed in the United States with
a proven safety record with over 10
years of monitoring

Vaccines protect your
child before exposure to
the disease. That is why
it is recommended that
your child is vaccinated
earlier rather than later,
long before they are
exposed to HPV

How many cancers are linked with HPV each year?
Back of throat
Cervical
Anal
Vulvar
Penile
Vaginal
Total

Women
2,200
10,900
4,200
2,800
0
600
20,700

Men
11,300
0
2,000
0
800
0
14,100

HPV vaccination can prevent up to 90% of HPV
cancers

Information from this
brochure can be found at:
www.cdc.gov/hpv/parents
/vaccine.html
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Results
•

The HPV vaccination brochures were placed in the lobby and various rooms in the family medicine clinic for patients,
parents and providers to read.

•

100% of the medical providers surveyed at the Newtown Family Medicine practice believe that the brochure will help
families make an educated decision regarding HPV vaccination of their child.

•

According to the medical providers at Newtown Family Medicine, the most common reasons parents deny HPV
vaccination for their children are:

•

•

Believe they are too young to get HPV (5 medical providers)

•

Think the vaccine may be harmful (5 medical providers)

•

Believe the vaccine is only for females (2 medical providers)

•

Not enough evidence to support the benefits (0 medical providers)

•

Not enough time during the visit to discuss fully (0 medical providers)

The perceived estimation of HPV vaccination vs. the actual proportion of children and adolescents vaccinated for HPV
according to the survey done by 12 Newtown Family Medicine medical providers (medical assistant, MD, APRN, PA)
Results
Perceived Vaccination rates:
• Males: 44.4% ± 17%
• Females: 66.7% ± 10%
Actual Vaccination rates
• Males: 48.7%
• Females 53.7%

100%

Percieved
Actual

80%
60%
40%
20%
0%

Males

Females

Conclusion
There is no significant difference between the perceived male
vaccination rates and the actual value demonstrating that
medical providers at Newtown Family Medicine have an
accurate understanding on the under vaccination of male
patients. However, the medical providers in the clinic
overestimated the amount of females vaccinated for HPV on
average by 13%.
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Effectiveness and Limitations
•

The effectiveness of this intervention will be determined in future months by the proportion of
males receiving the HPV vaccine due to the information provided by the brochure.

•

Future assessment of effectiveness

•

•

A survey to patients in the clinic regarding their perception of HPV vaccination for both males and females before and after
reading the brochure.

•

A survey to providers to evaluate if they were more likely to speak with patients regarding HPV vaccination during the
encounter if the brochure was in the room.

•

Determine if the presence of the brochure in the clinic, increased interest in HPV vaccination.

Limitations of the project
•

The effectiveness of the brochure is dependent on its availably for patients.

•

Due to limited time constraints, follow up on the effectiveness of the brochure in the clinic could not be evaluated.

•

Patients may have strong beliefs toward HPV vaccination that may not change due to the information provided in the
brochure.
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Future Projects
• Distribute brochures to other Family Medicine and Pediatric clinics in
Fairfield County, CT.
• Compile data on the effectiveness of the brochure in increasing HPV
vaccination rates in both male and female patients.
• Collect data regarding HPV-related cancers in males in Connecticut and
determine if vaccination has led to a similar decrease seen in cervical cancer
for females.
• Share the results of the survey with other providers in order to highlight
common misconceptions and barriers to vaccinate children for HPV in
Connecticut.
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